Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Alkermes Plc (NASDAQ:ALKS)

58.25
Delayed Data
As of 4:00pm ET
 +0.54 / +0.94%
Today’s Change
39.65
Today|||52-Week Range
62.50
+4.80%
Year-to-Date
No recent news for Alkermes Plc.

Today’s Trading

Previous close57.71
Today’s open57.72
Day’s range57.12 - 58.33
Volume867,865
Average volume (3 months)835,627
Market cap$8.9B
Dividend yield--
Data as of 4:00pm ET, 05/24/2017

Growth & Valuation

Earnings growth (last year)+9.21%
Earnings growth (this year)+54.56%
Earnings growth (next 5 years)+57.70%
Revenue growth (last year)+18.68%
P/E ratioNM
Price/Sales11.29
Price/Book7.35

Competitors

 Today’s
change
Today’s
% change
JAZZJazz Pharmaceuticals...-0.51-0.34%
TSROTESARO Inc+0.56+0.36%
SGENSeattle Genetics Inc+0.78+1.17%
PRGOPerrigo Company PLC-0.98-1.34%
Data as of 4:02pm ET, 05/24/2017

Financials

Next reporting dateAugust 3, 2017
EPS forecast (this quarter)-$0.02
Annual revenue (last year)$745.7M
Annual profit (last year)-$208.4M
Net profit margin-27.95%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman &
Chief Executive Officer
Richard F. Pops
President
Shane M. Cooke
Corporate headquarters
Dublin, Dublin

Forecasts